Pharma Excipients

News on Pharma Excipients

Fabrication of polymeric sorafenib coated chitosan and fucoidan nanoparticles: Investigation of anticancer activity and apoptosis in colorectal cancer cells

The most prevalent form of colon cancer also ranks high among cancer-related deaths globally. Traditional chemotherapy drugs do not provide sufficient therapeutic efficacy, and advanced colon cancer demonstrates considerable resistance to chemotherapy. As an oral kinase inhibitor, sorafenib (SOR) suppresses the growth of tumour cells, the formation…

Handbook of Nutraceuticals

See the new book, edited by R. Rajakumari and Sabu Thomas. Overview: Cutting-edge interdisciplinary book focused on the nutraceuticals and nano nutraceuticals Discusses all analytical techniques relevant to this field Assists…

Beyond Tableting Lubrication – PRUV® by JRS Pharma

PRUV® by JRS Pharma is a tablet lubricant designed for formulations in which other lubricants lead to formulation and/or manufacturing challenges. As opposed to the frequently used lubricant, magnesium stearate, PRUV® offers the following…

Excipient Reactivity and Drug Stability in Formulations

This is about the excipient used for achieving sustained release function undergone chemical reaction with the stabilizing agent used for the drug product leading to product quality failure from the desired dissolution behavior. The generic…